CEO: | Paul Carmelo Pagano |
Chief Finance Officer: | David Mark Anderson |
Non-Executive Chairman: | Gordon Roy Davis |
Senior Independent Non-Executive Director: | Andrew Norman Boteler |
Non-Executive Dir: | Sara Barrington |
Address: | 850 New Burton Road, Suite 201, Dover, Delaware, USA, 19904 |
Website: | https://www.lunglifeai.com/ |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
Domestic Listings: | LSE:LLA |
ISIN: | USU5500L1045 |
Currency | UK Pounds |
Share Price | 3.50p |
Change Today | 0.50p |
% Change | 16.67 % |
52 Week High | 26.50 |
52 Week Low | 0.90 |
Volume | 506,010 |
Shares Issued | 25.49m |
Market Cap | £0.89m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:38 | 75,000 @ 3.42p |
16:03 | 82,321 @ 3.64p |
15:57 | 2,000 @ 3.37p |
15:28 | 120,000 @ 3.75p |
14:44 | 33,635 @ 3.55p |
You are here: research